Editorial Comment from Dr Ide to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer

MeSH terms

• Adjuvants, Immunologic / therapeutic use
• Administration, Intravesical
• BCG Vaccine* / adverse effects
• Humans
• Mycobacterium bovis*
• Neoplasm Invasiveness
• Neoplasm Recurrence, Local / epidemiology
• Recurrence
• Urinary Bladder Neoplasms* / drug therapy